Shares of Avantor, Inc. (NYSE:AVTR – Get Free Report) have been given an average rating of “Hold” by the fifteen brokerages that are currently covering the firm, MarketBeat reports. Eight analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 1-year target price among brokers that have covered the stock in the last year is $15.9615.
AVTR has been the topic of several research analyst reports. Raymond James Financial lifted their target price on Avantor from $14.00 to $16.00 and gave the company an “outperform” rating in a research note on Thursday, October 16th. Stifel Nicolaus set a $12.00 target price on Avantor and gave the company a “hold” rating in a research note on Monday, August 4th. Royal Bank Of Canada dropped their price objective on Avantor from $20.00 to $17.00 and set an “outperform” rating on the stock in a report on Monday, August 4th. Robert W. Baird increased their price objective on Avantor from $15.00 to $17.00 and gave the stock an “outperform” rating in a report on Friday. Finally, Barclays upped their target price on Avantor from $13.00 to $15.00 and gave the stock an “overweight” rating in a research report on Thursday, October 2nd.
View Our Latest Analysis on Avantor
Insider Activity at Avantor
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of the company. Citizens Financial Group Inc. RI acquired a new position in shares of Avantor in the third quarter valued at $229,000. New York State Teachers Retirement System raised its stake in shares of Avantor by 3.9% in the third quarter. New York State Teachers Retirement System now owns 383,415 shares of the company’s stock valued at $4,785,000 after purchasing an additional 14,428 shares in the last quarter. SG Americas Securities LLC raised its stake in shares of Avantor by 250.3% in the third quarter. SG Americas Securities LLC now owns 129,876 shares of the company’s stock valued at $1,621,000 after purchasing an additional 92,798 shares in the last quarter. Tran Capital Management L.P. acquired a new position in shares of Avantor in the third quarter valued at $691,000. Finally, Spire Wealth Management raised its stake in Avantor by 31.0% during the third quarter. Spire Wealth Management now owns 4,597 shares of the company’s stock worth $57,000 after acquiring an additional 1,089 shares in the last quarter. 95.08% of the stock is currently owned by institutional investors and hedge funds.
Avantor Price Performance
NYSE AVTR opened at $15.44 on Wednesday. The stock’s 50-day moving average price is $13.33 and its two-hundred day moving average price is $13.34. The company has a current ratio of 0.98, a quick ratio of 0.67 and a debt-to-equity ratio of 0.48. The company has a market cap of $10.52 billion, a PE ratio of 15.59, a PEG ratio of 5.03 and a beta of 0.98. Avantor has a 1 year low of $10.82 and a 1 year high of $23.70.
Avantor (NYSE:AVTR – Get Free Report) last posted its quarterly earnings data on Friday, August 1st. The company reported $0.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.01). Avantor had a return on equity of 11.39% and a net margin of 10.31%.The company had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same quarter in the previous year, the firm posted $0.25 EPS. Avantor’s quarterly revenue was down 1.1% on a year-over-year basis. On average, analysts predict that Avantor will post 1.06 EPS for the current year.
About Avantor
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Featured Articles
- Five stocks we like better than Avantor
- Airline Stocks – Top Airline Stocks to Buy Now
- PulteGroup Is Down But Not Out—Here’s What Wall Street Missed
- What is the Shanghai Stock Exchange Composite Index?
- Cleveland-Cliffs Breaks to New Highs on Earnings, More Upside?
- Trading Stocks: RSI and Why it’s Useful
- Is Landstar the Next Big Winner in Transportation Stocks?
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
